<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Recent human studies reveal that <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> induces procoagulant and antifibrinolytic effects in blood that may contribute to a greater risk of <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo>, but the direct relationship between <z:mp ids='MP_0001559'>high blood glucose levels</z:mp> and <z:mp ids='MP_0005048'>thrombosis</z:mp> has not yet been investigated </plain></SENT>
<SENT sid="1" pm="."><plain>We performed a number of experiments to clarify whether <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> was causally related to <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo> and whether the combined stimulus of <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> and <z:mp ids='MP_0001845'>inflammation</z:mp> would enhance the thrombotic effect </plain></SENT>
<SENT sid="2" pm="."><plain>In a model of <z:chebi fb="2" ids="30808">ferric-chloride</z:chebi>-induced carotid artery <z:mp ids='MP_0005048'>thrombosis</z:mp>, <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> did not influence the time to occlusion in mice pretreated with <z:chebi fb="1" ids="9288">streptozotocin</z:chebi>, but the rate of <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> formation was accelerated </plain></SENT>
<SENT sid="3" pm="."><plain>This effect was associated with increased thrombin generation and could not be explained by changes in vessel-wall tissue factor activity </plain></SENT>
<SENT sid="4" pm="."><plain>The prothrombotic effect of <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> was assessed in a separate experiment, showing that collagen/thrombin-induced platelet procoagulant activity was increased in hyperglycemic mice </plain></SENT>
<SENT sid="5" pm="."><plain>The effect of <z:mp ids='MP_0001845'>inflammation</z:mp> was studied by injecting a low dose of endotoxin that caused a systemic inflammatory state after 24 h (increased plasma levels of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor alpha, interleukin-6 and monocyte chemotactic protein 1 in diabetic and nondiabetic mice) associated with a mild delay in <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> formation </plain></SENT>
<SENT sid="6" pm="."><plain>This reduced rate of <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> formation was attenuated by <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>Together, these data establish a discrete but clear contribution of <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> in experimental <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo> </plain></SENT>
</text></document>